Project Grant 2052603
Award Date 5/1/21
Completion Date 4/30/22
Dollars Obligated $255K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Champaign, IL 61820, USA
Similar Awards
- This $254,580 National Science Foundation Technology, Innovation, and Partnerships project grant funds the development of artificial intelligence-mediated orthopedic implant design and selection software by Med Dimensions, LLC. The Phase I small business innovation research project aims to create a machine learning system that incorporates bone density screening and 2D to 3D reconstruction to generate anatomically-derived implants and guide implant placement for veterinary use. By integrating...
- Oregon State University will receive $500,000 from the National Science Foundation under the Technology, Innovation, and Partnerships program to develop cancer therapeutics for dogs. Specifically, the university will construct and test prototype dual epitope-binding therapeutic antibodies targeting the canine PD-1 protein for the treatment of canine cancers. Researchers will design various single domain antibody configurations and select an optimal construct using recombinant DNA methods and...
- This STTR Phase II Cooperative Agreement award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program provides $1,000,000 in funding to Simmbion LLC to develop and demonstrate the safety and tolerability of a novel "living pharmacy" cellular factory approach for treating diabetes and obesity in cats. The award aims to show how a single injection can effectively control blood glucose and weight gain in companion animals for up to 12...
- The National Science Foundation Division of Industrial Innovation awarded a $256,000 Project Grant to Lexington, KY-based Lepidext, Inc. under the Engineering (47.041) federal grant program. The grant will support Lepidext's SBIR Phase I project to develop oral delivery systems for sterilizing strains of a sexually-transmitted insect virus. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. The 12-month...
- Hera Health Solutions Inc. received a $275,000 National Science Foundation Project Grant under the NSF Technology, Innovation, and Partnerships program to develop a biodegradable contraceptive-releasing implant. The award aims to advance long-acting reversible contraception by creating an implant that delivers consistent hormone doses and does not require surgical removal. During the one-year period from May 1, 2023 to April 30, 2024, the company will characterize the drug delivery scaffold,...
- Infinifluidics Inc. received a $256,000 National Science Foundation Project Grant under the Engineering (47.041) federal grant program. The grant supports development of on-demand continuous and sterile manufacturing of injectable drug delivery systems at industrial scale on a portable microfluidic chip from July 1, 2021 to June 30, 2022. The Engineering program seeks to improve quality of life and economic strength through innovative engineering research and education. This award will allow...
- The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to Current Surgical Inc. from May 15, 2021 to November 30, 2021 under the Engineering program (CFDA 47.041). The grant funds the development of a smart needle for precise tumor ablation. The NSF Engineering program supports innovation, creativity, and excellence in engineering research and education to improve quality of life and economic strength. This award advances those goals by...
- This National Science Foundation (NSF) Project Grant award of $275,000 to Zealous Research LLC is part of the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The project aims to develop a single-chip microfluidic platform to automate and optimize in vitro fertilization (IVF) processes, including sperm selection, sperm capacitation, and egg fertilization. The goal is to create a user-friendly, affordable, and high-throughput platform that can increase IVF success rates and...
- The National Science Foundation Division of Industrial Innovation awarded Epirus, Inc. a $243,000 Project Grant under the Engineering (CFDA 47.041) federal grant program. The grant funded research and development of antiviral electromagnetic pulses to address the COVID-19 pandemic from December 2021 through November 2022. As part of its mission to foster innovation in engineering, the Engineering program supported Epirus's work developing technology with potential applications to detect and...
- This $131,910 Project Grant awarded by the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) to Virginia Polytechnic Institute & State University (Virginia Tech) seeks to further the development of histotripsy, a non-thermal ablation technique, for the treatment of osteosarcoma (OS) in dogs. The project aims to: 1) investigate the treatment parameters and strategies needed for complete ablation of ex vivo canine OS tumors, and 2) test these strategies in pilot clinical...
Epivara, Inc. received a $254,760 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041) to develop a safe and effective injectable alternative to surgical spays in female dogs. The award period runs from May 1, 2021 through April 30, 2022. The Engineering program seeks to improve quality of life and economic strength through fostering innovation in engineering research and education. This award will support Epivara's research into developing a non-surgical sterilization method for female canines that could provide animal welfare benefits over traditional surgical spaying procedures.
Generated 1/6/24, 12:34 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $254.8k | 4/21/21 |